# data[].attributes.body
mm

# data[].attributes.body
The over all Stock Market Game Experience was interesting. Trading, finding and buying stocks where difficult. Our stocks Always fluctuated up and down, that is except SHOO that stock was quite constant. we where never sure whether to sell because our stock changed too much but some decisions had to be made. My team and I felt the stock Market Game was difficult bu at the same time a good experience and it got us to realize that the Stock market is not as easy as we though it was.

# data[].attributes.body
Steven Madden makes its profits by designing, producing and distributing products through its retail stores, its website, and department stores. It also profits from its licensing agreements. The company's wholesale customers consist of department stores and specialty stores, including independent boutiques. Approximately 69% of wholesale revenue is generated from department and specialty stores, including Macy’s, DSW, Nordstrom, Famous Footwear, Dillard’s and Lord & Taylor as well as mid−tier department stores and catalog retailers, including Victoria’s Secret. So the products are all over and they rack in money

# data[].attributes.body
This company has been through a lot the company was over-promoted (even fraudulently promoted) and the stock was manipulated. Jordan Belfort (the CEO of Stratton) had large undisclosed positions (he admits this in his book) and was actively involved in the manipulation of the stock Eventually the manipulation scheme comes crashing down. Steve Madden is charged with stock fraud and pleads guilty. He went to prison.

This affected the stocks

# data[].attributes.body
We though Steve Madden's company would bring us good money because his company is known around the world for manufacturing shoes, handbags, accessories, sun wear, outerwear, belts and jewelry.

These items rack in money in all places and his products are top notch

# data[].attributes.body
The youngest of three brothers, he started the company with $1,100 in 1990 by selling shoes out of the trunk of his car. The brand reported revenues of $1.23 billion in 2012(FY 2012),and is sold throughout the world. There are roughly 100 Steve Madden retail stores across the United States. While the company and its stores focus primarily on Steve Madden products, they also carry three more subcategorized Steve Madden lines; Madden Girl, STEVEN by Steve Madden and Freebird by Steven.

Internationally, Steve Madden has a presence in over 55 countries with roughly 185 retail stores & 180 conssesions.

# data[].attributes.attachment_link.readable_text
This end of month report tallied results from here as verified using Yahoo Finance data for healthcare sector stocks as of market closing prices November 1 along with analyst mean target price results one year hence. The comparison found 4 stocks exposing 12.86% to 17.16% price upsides.

Eli Lilly and Company (NYSE: LLY) the Indianapolis based drug manufacturer - major with 12.86% showed the lowest upside of those four. One step up, Merck & Co. Inc. (NYSE: MRK) the Whitehouse Station, NJ based drug manufacturer - major posted a 15.83% upside. Next to the best, Baxter International, Inc. (NYSE: BAX) a medical instruments and supplies company from Deerfield, IL showed 16.14% upside. At the top, Mine Safety Appliances Co. (NYSE: MSA) the Cranberry Twp., PA based Medical Appliances & Equipment firm pushed a 17.16% upside to lead those four. Six other Healthcare dogs back in the pack showed 5.11% to 11.82% price upsides.

On the downside, four stocks exhibited pending price slumps of 3.77% to 7.48% based on 1 yr. analyst mean target pricing. Kindred Healthcare, Inc. (NYSE: KND) a Louisville, KY based long-term care facilities firm presented the weakest 3.77% bearish sentiment while Meridian Bioscience, Inc. (NASDAQ: VIVO) a Cincinnati based diagnostic substances provider weighed 7.48% to the downside to most tempt hungry bears.

The charts above used one year mean target price set by brokerage analysts multiplied by the number of shares in a $1k investment to compare Healthcare sector stocks showing the highest upside and downside price potential into 2014 out of 20 selected by yield. The number of analysts providing price estimates was noted after the name of each stock. Three to nine analysts were considered optimal for a valid mean target price estimate.

This series of articles started applying dog dividend methodology in the fall of 2011 to reveal possible buy opportunities in each of eight major market sectors listed by Yahoo Finance: basic materials, consumer goods, financials, healthcare, industrial goods, services, technology, and utilities.

This report presumed yield (dividend / price) dividend dog methodology applied to any sector and compared that sector side by side with the Dow industrial index leaders. Below, the Arnold Healthcare Sector top dog selections for October were disclosed step by step.
Dog Metrics Filtered Out Ten Top Healthcare Stocks

Top ten healthcare sector dogs showing the biggest dividend yields by this screen as of November 1 represented four industries. Top healthcare sector stock was one of six drug manufacturers - major on this list: AstraZeneca PLC (NYSE: AZN). Nordion Inc. (NYSE: NDZ), second dog, represented the medical laboratories & research industry. In third place, Select Medical Holdings Corporation (NYSE: SEM) was one of two hospitals representatives. The other hospitals firm, Concord Medical Services Hldg Ltd. placed ninth. PetMed Express (NASDAQ: PETS), in fourth, represented drug delivery firms. The other five major drug manufacturers placed fifth through eighth, and tenth: GlaxoSmithKline (NYSE: GSK); Eli Lilly and Company; Merck & Co. Inc.; Sanofi SA (NYSE: SNY); Novartis AG (NYSE: NVS) completed the top ten healthcare dogs.

Dividend vs. Price Results Compared to Dow Dogs

The graph below of relative strengths of the top ten Healthcare sector dogs by yield as of market close 11/1/2013 compared to those of the Dow industrials index was prepared to show projected annual dividend history from $10,000 invested as $1k in each of the ten highest yielding stocks along with the total single share price of those ten stocks with the data points shown in green for price and blue for dividends.
Actionable Conclusion (1): Healthcare Very Bearish While Dow Dogs Dithered
The Healthcare collection of dividend payers reverted to a very bearish course after September as total single share price dropped 23.6% and aggregate dividend from $10k invested as $1k in each of the top ten healthcare dogs increased at a rate of 13% for the period. The healthcare pack exited overbought territory as aggregate single share price dropped below the dividend derived from $1K invested in each. The fully bearish market signal was emphasized by the author's use of a more inclusive stock screen for price and dividend data.

For the Dow dogs, meanwhile, projected annual dividend from $10k invested as $1K in each of the top ten Dow dogs dropped just 0.6% since September, while aggregate single share price swooned 11%, ending a brief bullish track. The Dow dogs overbought condition in which aggregate single share price of the ten exceeded projected annual dividend from $1k invested in each of the ten shrank. The overhang was $198 or 53% in June, then shrunk to $153 or 41% in July, compressed to $125 or 33% in August then expanded to $161 or 43% for September, then shrank down to $111 or 30% for October.

To quantify the top dog rankings, analyst mean price target estimates provided a "market sentiment" gauge of upside potential and so were added to the simple high yield "dog" metric used to dig out bargains.

Actionable Conclusion (2): Wall Street Wizard Wisdom Willed An 7.4% Net Gain from Top 20 Healthcare Dogs Come 2014

The top twenty dogs from the Healthcare sector were graphed below to show relative strengths by dividend and price as of November 1, 2013 and those projected by analyst mean price target estimates to the same date in 2014.

A hypothetical $1000 investment in each equity was divided by the current share price to find the number of shares purchased. The shares number was then multiplied by projected annual per share dividend amounts to find the dividend return. Thereafter the analyst mean target price was used to gauge the stock price upsides and net gains including dividends less broker fees as of 2014.

Historic prices and actual dividends paid from $20,000 invested as $1k in each of the highest yielding stocks and the aggregate single share prices of those twenty stocks divided by 2 created data points for 2013. Projections based on estimated increases in dividend amounts from $1000 invested in the twenty highest yielding stocks and aggregate one year analyst target share prices from Yahoo Finance divided by 2 created the 2014 data points green for price and blue for dividend graphed from the plus row in the chart below exhibiting the 7.39% net gain.

Factoring in a 1.05% loss from the four negative net stocks introduced above, a net gain of 6.34% results.

Yahoo projected a 4% lower dividend from $10K invested as $1k in ten dogs in this group while aggregate single share price for those ten was projected to increase by 5% in the coming year.

The number of analysts contributing to the mean target price estimate for each stock was noted in the next to the last column on the charts. Three to nine analysts was considered optimal for a valid projection estimate. Estimates provided by one analyst were not applied (n/a).

A beta (risk) ranking for each stock was provided in the far right column of the above chart. A beta of 1 meant the stock's price would move with the market. Less than 1 showed lower than market movement. Higher than 1 showed greater than market movement. A negative beta number indicated the degree of a stocks movement opposite of market direction.

Actionable Conclusion (3): Analysts Forecast Ten 2014 Healthcare DiviDog Net Gains of 6.4% to 17.8%

Six of the ten top dividend yielding healthcare dogs were verified as being among the ten gainers for the coming year based on analyst 1 year target prices. So this month the dog strategy for the financial sector as graded by Wall St. wizards was 60% accurate.

Ten probable profit generating trades were revealed by Thompson/First Call in Yahoo Finance for 2014:

Mine Safety Appliances Co. netted $178.30, based on dividends four analysts less broker fees. The Beta number showed this estimate subject to volatility 61% more than the market as a whole.

Merck & Co. Inc. netted $178.33 based on dividends plus the mean of annual price estimates from fifteen analysts less broker fees. The Beta number showed this estimate subject to volatility 48% less than the market as a whole.

Baxter International, Inc. netted $171.18 based on estimates from fourteen analysts plus dividends less broker fees. The Beta number showed this estimate subject to volatility 43% less than the market as a whole.

Eli Lilly and Company netted $147.92 based on dividends plus mean target price estimate from seventeen analysts less broker fees. The Beta number showed this estimate subject to volatility 68% less than the market as a whole.

Nordion Inc. netted $146.47 based on dividends plus the mean of annual price estimates from five analysts less broker fees. The Beta number showed this estimate subject to volatility 48% less than the market as a whole.

Abbott Labs (NYSE: ABT) netted $104.50 based on estimates from sixteen analysts plus dividends less broker fees. The Beta number showed this estimate subject to volatility 34% less than the market as a whole.

Sanofi netted $104.50, based on dividends plus mean target price estimate from four analysts less broker fees. The Beta number showed this estimate subject to volatility 14% more than the market as a whole.

Select Medical Holdings netted $92.79 based on dividend plus a mean target price estimate from six analysts less broker fees. The Beta number showed this estimate subject to volatility 37% more than the market as a whole.

PetMed Express Inc. netted $77.77 based on dividends plus mean target price estimate from five analysts less broker fees. The Beta number showed this estimate subject to volatility 49% greater than the market as a whole.

AbbVie Inc. (NYSE: ABBV) netted $63.74 based on a mean target price estimate from twelve analysts combined with projected annual dividend less broker fees. The Beta number showed this estimate subject to volatility 593% more than the market as a whole.

The average net gain in dividend and price was 12.64% on $10k invested as $1k in each of these ten dogs. This gain estimate was subject to average volatility 1% greater than the market as a whole.

Actionable Conclusion (4): (Bear Alert) Analysts Forecast 4 Healthcare DiviDogs to Post Net Losses of 2.8% to 9.3% By October 2014

Four probable losing trades revealed by Yahoo Finance for 2014 were:

Concord Medical Services (NYSE: CCM) lost $27.66, based on dividend and mean target price estimates from three analysts including $20 of broker fees. The Beta number showed this estimate subject to volatility 13% less than the market as a whole.

Kindred Healthcare, Inc. lost $28.52 based on dividends and the mean of annual price estimates from eight analysts including $20 of broker fees. The Beta number showed this estimate subject to volatility 175% greater than the market as a whole.

Bristol-Myers Squibb (NYSE: BMY) lost $60.78, based on dividends and a mean target price estimate by eighteen analysts including $20 of broker fees. The Beta number showed this estimate subject to volatility 71% less than the market as a whole.

Meridian Bioscience, Inc. lost $93.40 based on dividend and a mean target price estimate from seven analysts including broker fees. The Beta number showed this estimate subject to volatility 40% more than the market as a whole.

The average net loss in dividend and price was over 5.2% on $4k invested as $1k in each of these four dogs. This loss estimate was subject to average volatility 33% more than the market as a whole.

The net gain and loss estimates above did not factor-in any foreign or domestic tax problems resulting from distributions. Consult your tax advisor regarding the source and consequences of "dividends" from any investment.

Stocks listed above were suggested only as possible starting points for your index dog dividend stock purchase research process. These were not recommendations.

Disclaimer: This article is for informational and educational purposes only and should not be construed to constitute investment advice. Nothing contained herein shall constitute a solicitation, recommendation or endorsement to buy or sell any security. Prices and returns on equities in this article except as noted are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling same.

Disclosure: I am long JNJ, PFE, GE, INTC, MCD, MSFT, T, VZ. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

# data[].attributes.attachment_link.title
4 Healthcare Sector Dogs Hype 13% To 17% October Upsides; 4% To 7.5% Downsides

# data[].attributes.attachment_link.description
This end of month report tallied results from here as verified using Yahoo Finance data for healthcare sector stocks as of market closing prices November 1 along with analyst mean target price results one year hence. The comparison found 4 stocks exposing 12.86% to 17.16% price upsides.

# data[].attributes.attachment_link.readable_text
( DSW NYSE:DSW), the American footwear retailer, has widely underperformed the market over the last several months. However, a strong fourth-quarter report could help get DSW back on track. The results are due out on March 18, so let's take a look at the most recent release and the analyst expectations for the upcoming report to determine if this is our opportunity to buy DSW or if we should avoid this beaten-down stock.

The last time out
On Nov. 26, DSW released third-quarter results for fiscal 2013. Here's a breakdown of the report and a year-over-year comparison:

Earnings per share increased 14% and revenue increased 6.8% year over year, as comparable-store sales declined 0.7%. DSW also raised its full-year outlook, but this did not draw attention away from the disappointing revenue results, as analysts were expecting higher sales driven by back-to-school shopping and the start of the holiday season.

CEO Mike McDonald tried to keep the negativity contained, saying, "We were encouraged by the improvement in traffic and sales at the end of the quarter, as the fall selling season got off to a delayed start." This quarter ended on Nov. 2, so it appears that shoppers were waiting for holiday promotions to do their shopping.

Nonetheless, the market reacted negatively and sent DSW shares tumbling 4.81% on the day of the release; this initial decline quickly turned into a heated sell-off, and the stock now sits more than 18.5% below where it was before the release.

Expectations and what to watch for
Fourth-quarter results are due out before the market opens on March 18, and the current estimates expect negative growth; here's an overview:

These expectations call for earnings per share to decrease 15.9% and revenue to decrease 3.4% year over year; these are dismal estimates and would result in DSW's weakest quarter of the year, but they reflect the current challenges within the retail industry. Other than the key metrics, it will be important to watch for two things: the change in the gross margin and, most important, the company's outlook for fiscal 2014:

1. The retail environment was highly promotional during the holiday season, and this is likely to greatly affect DSW's gross margin. In the year-ago quarter the gross margin came in at 28.9%, so keep an eye out for this statistic and make sure it does not drop too drastically.

2. It will be crucial for DSW to provide an outlook on fiscal 2014 that is within analyst expectations; currently, the estimates call for earnings per share in the range of $1.93-$2.21 on revenue of $2.5 billion-$2.7 billion.

Overall, the estimates seem quite low for the quarter, but I would still be cautious from an investment standpoint. The stock has been in a free fall to begin 2014 and we do not want to try to catch a falling knife.

With this said, if the earnings come in strong and the outlook on 2014 is within the expected range, a Foolish investor might want to consider initiating a position in DSW as long as the stock does not spike too high in response.

(( What are the brands sold by DSW saying?
Steve Madden NASDAQ:SHOO) and Wolverine World Wide NYSE:WWW) are two of the brand families sold at DSW locations; Steve Madden's brands include Madden Girl, Steve Madden, and Steven by Steve Madden, and Wolverine World Wide's brands include Keds, Merrell, Saucony, Sperry, and Wolverine. Both of these companies have recently reported their earnings, so let's take a look at what they accomplished, as this will give us insight into the condition of the footwear industry:
Steve Madden -- Feb. 25:

Steve Madden's earnings per share increased 10.2% and revenue increased 8.7% year over year. Its company-owned retail stores reported that comparable-store sales were down 6.7%, but sales from the wholesale business grew 10.6% -- this is the segment that does business with retailers like DSW.

Steve Madden's CEO, Edward Rosenfeld, spotlighted these statistics, saying, "While we are cautious on the near term outlook for our retail segment due to continued softness in traffic and sales trends, we are confident that we can maintain solid momentum in our wholesale business, and we expect to deliver another year of strong performance in 2014." Basically, the company expects continued weakness in its own stores while growth occurs elsewhere, like at DSW.
Wolverine World Wide -- Feb. 18:

Wolverine's adjusted earnings per share decreased 8.3% and revenue increased 13.6% year over year, driven by "excellent results" from three of its largest brands, Merrell, Keds, and Saucony -- all of these can be found at DSW's stores. The company added that the momentum in its brands has carried over into 2014 and it expects continued growth throughout the year, which is a positive sign for retailers like DSW.

In summary, the solid results and positive outlook from Steve Madden and Wolverine World Wide are positive indicators for DSW, but they still do not make a strong enough case to buy DSW right now.

The Foolish bottom line
DSW's stock has fallen more than 10% in 2014, but a strong fourth-quarter report could help turn things around. The current analyst estimates seem within reach for DSW, but you should still exercise caution when considering an investment today due to the negativity surrounding the retail industry. I believe Foolish investors should wait for the report to come out to get the most up-to-date financial information so we can make an educated decision on whether or not to put our money to work.

# data[].attributes.attachment_link.title
DSW: Will the Footwear Retailer Sprint Past Earnings Expectations?

# data[].attributes.attachment_link.description
( DSW NYSE:DSW), the American footwear retailer, has widely underperformed the market over the last several months. However, a strong fourth-quarter report could help get DSW back on track.

# data[].attributes.body
For every stock we bought 100 shares for each, the highest we went was 150 for the Monster Corporation. At the time we believed that monster was doing really well, but due to how much money was lost we decide to sell the stock. The price for each stock would always be under $100, because we would want a variety of stocks. We gained around $400 throughout the weeks of the stock market game.

# data[].attributes.body
The global leader in latching system technology, has expanded its Dortec manufacturing facility to begin producing electronic systems and modules for the automotive industry. The $1.5-million expansion will create 75 new jobs and further positions Magna Closures to meet the growing trend of increased electronic functionality in automobiles.

# data[].attributes.body
The company has taken steps going forward by capping executive compensation at 3% of the company’s profit. Still, company execs made more than $45 million in 2013, excluding Stronach. Time will tell whether the company is serious about reducing excessive pay to its top brass.

One of the reasons Magna’s stock price has done so well over the past few years is the company’s aggressive move into components for electric vehicle technology.

# data[].attributes.body
1. This company has 2,864 full-time employees.

2. Steve Madden owns and operates 121 retail stores, including 4 internet stores.

3. The company operates 5 business segments: wholesale footwear, wholesale accessories, retail, first cost and licensing.

4. The wholesale footwear provides footwear under Steve Madden Womens, Madden Girl, Steve Madden Mens, Madden, Steven, l.e.i, Olsenboye, Stevies and Steve Madden Kids, Betsey Johnson Shoes, Superga, FREEBIRD by Steven, Report, MadLove and Candies Brand.

5. Steve Madden shoes are sold in the US and Canada through the store and in stores like Nordstrom and Dillard's.

-Kylie Young

# data[].attributes.body
1. This company has 125,000 employees.

2. Magna International develops, manufactures, engineers, supplies and sells automotive products.

3. The company was founded in 1957 and is headquartered in Aurora, Canada.

4. Their competitors are Dana Holding Corporation, Lear Corp and Robert Bosch.

5. Magna International is the leading global automotive supplier with 316 manufacturing operations and 84 product development, engineering and sales centres in 29 countries.

-Kylie Young

# data[].attributes.headline
Facts about Select Medical Holdings Corporation 

# data[].attributes.subject
Facts about Select Medical Holdings Corporation 

# data[].attributes.body
1. This company has 21,100 employees.

2. SEM operates specialty hospitals and outpatient rehabilitation clinics.

3. The company was founded in 1996 and headquartered in Mechanicsburg, Pennsylvania.

4. SEM operates 108 long term acute care hospitals and 15 outpatient rehabilitation facilities in 28 states; and 1,006 outpatient rehabilitation clinics in 32 states and District of Columbia.

5. The company’s net income is $34,418.

-Kylie Young

# data[].attributes.body
We considered Magna International Inc in our portfolio because Magna manufactures auto parts that are supplied to General Motors, Ford Motor Company, and Chrysler.

Major customers were Volkswagen, BMW and Toyota.

Magna’s capabilities include the design, engineering, testing and manufacture of exterior systems, interior systems, seating systems, closure systems, vision systems, powertrain systems, electronic systems, roof systems, body & chassis systems, hybrid &

electric vehicle systems, and vehicle engineering & contract assembly.

# data[].attributes.body
Magna International Inc was one of the biggest automobile parts manufacturers in North America and Canada. It was found in 1957 by Frank Stronach, it was originally named “Multimatic” but once it merged with Magna Electronics it became Magna International in 1973. Magna has approximately 125,000 employees in 316 manufacturing operations and 84 product development, engineering and sales centre’s in 29 countries. Magna operates under a corporate constitution which calls for distribution of profits to employees and shareholders.

# data[].attributes.body
http://online.barrons.com/listings-stock-funds

http://finance.yahoo.com/

http://www.thestreet.com/

# data[].attributes.body
1. The Stock Gods biggest gainer was Steve Madden from the last 10 weeks. Its the breadwinner because it was our most stable stock, never losing any money until the last day.

2. Our biggest loser for the past few weeks was Kirkland. We usually sell off our bad stock after we lose a bit too much from that particular stock. Kirkland is the loser stock because nobody at this time has a high demand for refrigerators or kitchen appliances.

3. Overall, The Stock Gods made money rather lose money. We only made $400 and we didn’t lose any.

4. Our most stable stock was Steve Madden.

5. When we had it, Monster Energy was our most volatile stock.

6. We only sold the stock that was losing us money. We kept the stocks that were gaining money.

7. We used the teacup method on Steve Madden and Disney.

8. The stock had to be somewhat stable for the past months before we buy that certain stock. We would never buy stock that was unstable, we were always cautious when buying our stocks.

9. Jasmine mostly decided which companies to buy from looking at the graphs and seeing how stable that stock is. Also she would see if the company  manufactures products that we always use and need.